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 Abstract 
 
 
Retinal ganglion cells (RGCs) are projection neurons of the eye, which process and pass visual information 
collected in the eyes to the brain. However, epigenetic regulation of RGC fate specification remains poorly 
understood, in large part due to the technical challenges associated with purifying RGCs, which comprise 
only 1% of all retinal cells, and performing ChIP-seq profiling on a small number of cells. To overcome 
these limitations, we have purified RGCs from multiple mice by immunoppanning for Thy1, a surface 
marker on RGCs, and analyzed pulled chromatin by ChIP-seq for histone 3 acetylated at K27 (H3K27ac), 
which is an epigenetic marker of active (i.e. accessible) enhancers. We also utilized recently developed ChIP-
seq Kit for processing small cell number samples and ultra low chromatin input (truChIP Ultra Low Cell 
Chromatin Shearing Kit, Covaris; Zymo-Spin ChIP Kit, Zymo Research; and Accel-NGS 2S Plus DNA 
Library Kit, Swift Biosciences). Immunoprecipitation chromatin was sequenced and mapped to mouse 
reference genome (mm10), peaks were called using MACS2 (sheared RGC chromatin was used for 
background control), and peak annotation was performed using the HOMER software. We have identified 
enhancers that are active in RGCs and cross-referenced them to the mouse cell types, and some were novel 
and unique to RGCs. Next, using HOMER software, we performed DNA motif analysis in the identified 
enhancer regions and predicted the transcription factors to those we have identified as expressed in 
RGCs by mRNA-seq. These analyses enabled us to associate the transcription factors that are 
expressed in RGCs with the enhancers that are active in RGCs, and also to predict which of these 
transcription factors could bind to the same enhancers, and thus may cooperate with each other in 
regulating gene expression in RGCs. Taken together, our epigenetic profiling of RGCs predicted 
active enhancers, which are potentially unique to RGCs, as well as predicted the interactions of 
transcription factors and enhancers, which are involved in determining RGC-specific gene 
program.
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Chapter 1: Introduction/Background 
 
 
1.1 Overview 
 
 
Retina ganglion cells (RGCs) are projection neurons of the eye, which located near the ganglion cell layer 
of the retina. They integrate the visual information collected in eyes and pass the information through the 
optic nerve into the brain for further processing.  
In gene control, regulation of transcription is the most common form. Enhancers located upstream or 
downstream from an associated gene are DNA regions that transcription factors can bind to and form a 
complex that recruits transcriptional machinery of the promoter of the gene to enhance the transcription.  
By binding to a specific DNA sequence, the transcription factors can control the rate of transcription of 
genetic information from DNA to mRNA. The activity of transcription factors enables genes to be 
specifically regulated during developing in variant types of cells. 
DNA sequencing is a laboratory approach to determine the precise sequence of nucleotides of a DNA 
molecule. The method was developed by Frederick Sanger. Next generation sequencing technologies that 
allow millions of DNA molecules to be sequenced at a time have become essential in studies of genomics, 
epigenomics, and transcriptomics. These recent technologies enable us to sequence DNA and RNA much 
more quickly and cheaply than the previous approach -- Sanger sequencing. Chromatin 
immunoprecipitation followed by high throughput sequencing, which also known as ChIP-seq, is popular 
in sequencing techniques to study genome-wide protein-DNA interactions. The approach of ChIP-seq 
combines chromatin immuniprecipitation with DNA sequencing to identify the binding sites of DNA 
associated proteins.  
Our goal is to integrate epigenetic and transcriptional regulation of RGCs development, in order to advance 
the understanding of RGCs biology and identify therapeutic targets that could help improve health and 
survival of injured RGCs.   We identified the active enhancers during RGCs differentiation and maturation. 
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The epigenetic studies can not only help us to investigate epigenetics of RGCs development but also 
predict which of the transcription factors could cooperate together in recruiting the transcriptional 
machinery to promoters of genes in RGCs. 
For my thesis project, I focused on performing epigenetic profiling of active enhancers in mouse retinal 
ganglion cells to study their development. We purified retinal ganglion cells from many mice by 
immunopanning for the surface marker Thy1 on them. The mice are come from different conditions include 
embryonic day 18, postnatal day 0 and adult. Each condition has two replicates with five mice ten eyes. The 
we analyzed chromatin by ChIP-seq for epigenetic markers of active enhancers. After sequencing, I mapped 
the DNA reads to the mouse reference genome so that I could identify the peaks that represent active 
enhancers in retinal ganglion cells. For the control sample, I used fragmented background DNA without 
purifying. After getting peaks alignment to the mouse genome and cross-referencing to the mouse enhancers 
identified in multiple tissues from the ENCODE database, I discovered a number of novel enhancers that 
maybe specific to only retinal ganglion cells because we used highly purified retinal ganglion cells which only 
represent 1% of all retinal cells. Then I integrated the ChIP-seq result with the gene expression profile of 
retinal ganglion cells that I have performed using our mRNA-seq dataset. By integrating them together, I 
could find the first down stream gene of each enhancer that expressed in retinal ganglion cells. I hypothesized 
that the enhancer is involved in regulating the down stream gene expression. I also associated the transcription 
factors that are expressed in retinal ganglion cells with the active enhancers and predicted which of these 
transcription factors could bind to the same enhancers. They were close enough to cooperate with each other 
in forming transcriptional complexes that regulate gene expression in retinal ganglion cells. I validated the 
novel enhancers by qPCR.  
This chapter provides background into the relevant experimental materials, sample types and 
bioinformatics tools studied in my M.S. thesis research. 
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1.2 Retinal Ganglion Cells 
 
 
1.2.1 Retina 
 
 
Vision is a complicated process that requires components of eye and brain to work together. The first step in the 
process of the sense is carried out in the retina. The retina is a complex transparent light-sensitive tissue that lines 
the inner surface of the back of the eyeball consisting of several layers. Only one of the layer in the mature 
mammalian retinas contains light-sensitive photoreceptor cells. The photoreceptor cells have two types – rods 
and cones, which are differentiated structurally by their distinctive shapes and functionally by their sensitivity to 
different kinds of lights1. Light must pass through the overlying layers to reach them. Rod photoreceptors can 
detect motion and provide black- white vision which means they function well in low-light level. Cones are more 
prominent in animals that are active during the day (most of the mammals) because they are responsible for 
central vision, color vision and perform better in medium and bright light. Rod cells are located throughout the 
retina and cones are concentrated in a small central area of the retina – macula. These two types of cells can take 
light focused by the cornea, lens and convert it into chemical and nervous signals which are transported to visual 
centers in the brain through the optic nerves2. 
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Figure 1: The structure of retina. Light are focused by the cornea and lens into the retina, where 
vision begins (Gary Heiting, OD).  
 
1.2.2 Ganglion cells 
 
 
Retinal neuronal neurons have six types: bipolar cells, ganglion cells, horizontal cells, retinal amacrine cells, 
rod and cone photoreceptors. Retina ganglion cells are a type of projection neuron which are the final output of 
the retina. They collect visual information from retinal neurons – photoreceptors via intermediate neuron types: 
bipolar and amacrine cells, and convey information to the rest of the brain for further processing3. The visual 
information is a type of chemical messages that is sensed by receptors on the ganglion cell membrane and the 
chemical messages are transformed into intracellular electrical signals by transmembrane receptors4. These 
messages are integrated within the dendrites and cell bodies of ganglion cells and transmitted through axon of 
ganglion cells. The optic nerve collects all the axons of the ganglion cells so that axons can terminate in brain 
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visual centers. Retinal ganglion cells only represent one percent of all retinal cells but they are all photosensitive. 
Their axons form the retinohypothalamic track and conduce to circadian rhythms and pupillary light reflex. 
 
1.3 Cis-regulatory Element 
 
 
Cis-regulatory elements (CREs) are regulatory elements of non-coding DNA that contain binding sites for 
transcription factors and play essential roles in cell development since they control development and 
physiology by regulating gene expression. The regulatory events contribute to the gene expression 
programs that determine the state of cells and the potential for differentiation into new cell types5.  
Promoters and enhancers are two types of cis-regulatory elements.  DNA sequences with promoter activity 
initiate transcription at transcription start sites and sequences with enhancer activity activate transcription 
initiation at promoters6. Regulation of transcription is the most common form of gene control, and the 
activity of transcription factors enables genes to be specifically regulated during development in variant 
types of cells. Cis-regulatory elements typically regulate gene transcription by binding to transcription 
factors. 
 
1.3.1 Promoter 
 
 
Promoters are regions of DNA where transcription of a gene controlled by RNA polymerase begins. 
Promoters are always about 100-1000 base pairs long and located directly upstream on the DNA or near 
the 5’ end of transcription start sites of genes. RNA polymerase and some necessary transcription factors 
can bind to the promoter sequences and initiate transcription (Figure 2). There are two types of promoters: 
the first one is core promoter elements that general transcription machinery including the RNA polymerase 
core enzyme and other general transcription factors could bind to. The recruitment of RNA polymerase II 
(Pol II) to the core promoter region can help the occurrence of the initiation protein-coding genes and 
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distinct non-coding regions transcription7. Another type is regulatory elements that bind sequence-specific 
transcription factors that include transcriptional activators and repressors5.  
 
1.3.2 Enhancer 
 
 
Enhancers are DNA short non-coding regions (50-1500bp) that transcription factors could bind to and form 
a complex that recruits transcriptional machinery to the promoter of a gene to regulate expression. When 
bound by specific transcription factors, enhancer sequences can enhance the transcription of an associated 
gene to increase the likelihood that transcription of the gene will occur.  
The region of enhancer sequences can be located up to 1 Mbp away from the gene, upstream or downstream 
from the transcription start site and also within introns so that they generally function independently at 
various distances from their target promoters8. Enhancer sequences function at a distance by forming 
chromatin loops so that enhancer and target gene can be brought into proximity. Enhancer elements are 
associated with histone modifications and histone H3K27ac can distinguish active enhancers from inactive 
or poised enhancer elements that contain H3K4mel alone9.  Active enhancers interact with transcription 
factors to regulate specific gene expression show more type-specificity of cell than promoters6.  
 
1.3.3 Transcription factor 
 
 
Transcription is the key process to transcribe the genetic information from DNA to make a protein where the DNA 
sequence of a gene is copied into a RNA molecule. Transcription factors (TFs) are proteins that regulate the 
transcription of genes by binding to a specific DNA sequence. These proteins help determine which genes are 
active in each cell, in other words, determine whether the gene’s DNA is transcribed into RNA. The chemical 
reactions of RNA synthesis are catalyzed by the enzyme RNA polymerase, using the gene’s DNA as a template. 
In this process, transcription factors can control when, where and how efficiently the RNA polymerase perform. 
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A single transcription factor can bind to many cis-regulatory elements, and hence control the expression of several 
genes, while many transcription factors may act together to regulate the expression of one gene10.  Transcription 
factors are a very diverse family of proteins and generally function in protein complexes which means a complex 
of transcription factors can cooperate with each other to regulate the expression of a specific gene. They may bind 
directly to the promoter regions of DNA (Figure 2), which locate at the upstream of a gene, or directly to the RNA 
polymerase molecule. In general, transcription factors work alone or with others to form a complex. They not only 
can act as a activator but also can act as a repressor to promote or block the recruitment of RNA polymerase to 
specific genes.  
Transcription factors contain at least one DNA-binding domain (DBD), with which they can attach to a specific 
sequence of DNA adjacent to the genes that they regulate. DBD is the unique characteristic of transcription factors, 
since many other proteins that also help to regulate the gene expression such as histone acetyltransferases, histone 
deacetylases and coactivators are lack DNA-binding domains.  
Theoretically, there are two classes of transcription factors: general transcription factors and specific transcription 
factors. General transcription factors are ubiquitous and interact with the core promoter region around the 
transcription start sites. Specific transcription factors always bind upstream of the initiation site and they vary 
considerably depending on the recognition sequences. 
There are three main mechanisms that transcription factors are used. The first one is stabilizing or blocking the 
binding of the RNA polymerase to DNA molecule. The second one is to catalyze the acetylation or deacetylation 
of histone proteins to weaken or strengthen the association of DNA with histones so that they make the DNA 
more or less accessible to transcription, thereby up-regulating or down-regulating transcription. The third one is 
to recruit coactivator or corepressor proteins to the transcription factor DNA complex. 
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Figure 2: The transcription factors bind to DNA regions and form a complex which recruits 
transcriptional machinery to the promoter of a gene to regulate its expression. 
 
1.4 Sequencing 
 
 
In genetics, sequencing is the general term that refers to any techniques designed to determine the precise order 
of nucleotides in a nucleic and acid molecule. 
 
1.4.1 Sanger sequencing 
 
 
Sanger sequencing is the first-generation sequencing method that is based on the selective incorporation of 
chain-terming dideoxynucleotides by DNA polymerase in vitro DNA replication. Sanger sequencing, 
which was first developed by Fred Sanger and his colleagues in 1977, has been the most widely used 
sequencing method for forty years. Sanger method can be used to determine the sequences of small 
fragments extracted from DNA molecules. The fragments are mapped to assemble the sequence of 
reference genome based on the overlapping regions. Although genomes are now sequenced by other 
alternative methods that are faster and cheaper, Sanger sequencing is still in a wide use for the sequencing 
9  
of individual fragments of DNA that are generated through polymerase chain reaction11.  
 
1.4.2 Next generation sequencing 
 
 
Next-generation sequencing, also known as high-throughput DNA sequencing, is a method that enables 
rapid sequencing of the base pairs in DNA or RNA molecules. By using next-generation sequencing, 
millions or billions of DNA strands can be sequenced in parallel, yielding redundant throughput and 
minimizing the need for the fragment-cloning method10. Next-generation sequencing can be used for 
transcriptomic analysis of mRNAs, small RNAs, noncoding RNAs, genome-wide methylation assays and 
high-throughput chromatin immunoprecipitation assays.  
 
1.4.2.1 DNA sequencing 
 
 
DNA sequencing is the approach to determine the precise order of nucleotides of a DNA molecule. Sequencing 
a short piece of DNA is relatively straightforward while sequencing an entire genome requires breaking the 
DNA of genome into shorter reads, sequencing the reads and assembling the small reads into a single long 
consensus. With the development of sequencing technology, genome sequencing is much faster and cheaper 
than it was when using the first generation sequencing method. 
Illumina sequencing is one of the common DNA sequencing method that determine the series of base pairs in 
DNA molecules with high data accuracy, simple workflow and a broad range of applications. This innovative 
and flexible sequencing system enables a wide use in genomics, transcriptomics and epigenetics. The Illumina 
sequencing workflow is composed of 4 basic steps – sample preparation, cluster generation, sequencing and 
data analysis. The preparation adds adapters to the ends of the DNA and through reduced cycle amplification, 
additional motifs are introduced, such as sequencing binding site, induces and regions complementary to the 
flow cell oligos. In the clustering process, each short fragment is isothermally amplified. The flow cell is a glass 
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slide with lanes, which are the channels coated with a lawn, composed of two types of oligos. Hybridization is 
enabled by one the two types of oligos on the surface. This oligo is complementary to the adapter region on one 
of the fragment strands. A polymerase creates a complement of the hybridized fragment. The double stranded 
molecule is denatured and the original template is washed away. Then the strands are amplified through bridge 
amplification. In the amplification process, the strand folds over and the adapter region hybridizes to the second 
type of the oligo on the flow cell. Polymerases generate the complimentary strand forming a double stranded 
bridge. The bridge is then denatured, resulting in two single stranded copies of the molecule that are tethered to 
the flow cell. The amplification is repeated over and over again to occur simultaneously for millions of clusters 
resulting in clonal amplification of all the fragments. After bridge amplification, the reverse strands are cleaved 
and washed off, leaving only the forward strands. The 3’ prime ends are blocked to prevent unwanted priming. 
Sequencing begins with the extension of the first sequencing primer to produce the first read. With each cycle, 
fluorescently tagged nucleotides compete for addition to the growing chain. Only one is incorporated based on 
the sequence of the template. After the addiction of each nucleotide the clusters are excited by a light source 
and a characteristic fluorescent signal is emitted. This process is so-called sequencing-by-synthesis. The 
emission wave length, along with the signal intensity, determines the base call. For a given cluster, all identical 
strands are read simultaneously and hundreds of millions of clusters are sequenced in a massively parallel 
process. After the completion of addition of the first read, the read product is washed away, the index one read 
primer is then introduced and hybridized to the template. The read is generated as the first read. After 
completion of the index read, the read product is washed off again and the 3’ prime ends of the template are 
deprotected. The template then folds over and binds to the second oligo on the flow cell. Index two is read in 
the same manner as index one. Polymerases extend the second flow cell oligo forming a double stranded bridge. 
This double stranded DNA is linearized and the 3’ prime ends are blocked. The original forward strand is 
cleaved off and washed away only leaving the reverse strand. Read two begins to be sequenced with the 
introduction of the read two sequencing primer. The sequencing steps are repeated until the desired read length 
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is achieved and then the read two product is washed away. During the laser excitation, the image is captured 
and the identity of the second base is recorded to determine the base call (Figure 3). This entire process generates 
millions of reads, representing all the fragments from the target DNA molecules. All of the sequencing cycles 
are repeated to determine the sequence of bases in a fragment, one base at a time12. The Illumina provides two 
fastq files containing the raw sequence data of both ends. The data are aligned and compared to a reference 
genome and sequencing differences are identified. 
 
Figure 3: The process of Illumina sequencing (Ben Faircloth) 
 
1.4.2.2 RNA sequencing 
 
 
RNA sequencing uses next-generation to transcriptome profiling. The transcriptome is the complete set of 
transcripts in a cell that represents only small percentage if the genetic code can be transcribed into RNA 
molecules including non-coding sequences. Each gene may produce more than one variant of mRNA since 
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there are alternative splicing, RNA editing, even alternative initiation and termination sites so that the 
transcriptome can capture a level of more complex genetic information than genome sequence13. We can use 
RNA sequencing to analyze the cellular transcriptome in order to understand the development of cells. RNA 
sequencing can only determine the sequences that are actively expressed in the cells, while DNA sequencing 
can give a genetic profile of entire genome. RNA sequencing also provides a more precise measurement to 
identify transcripts and their isoforms14.  
In general, total or fractionated (such as poly(A)+ selection) RNA molecules are converted to a library of cDNA 
fragments that are attached with adapters to one or both ends. After amplification, each molecule is sequenced 
in a high-throughput manner to get short sequences from one end or both ends(Figure 4)14 15. Next-generation 
sequencing technologies, such as Illumina sequencing, SOLiD sequencing and Roche 454 sequencing, can be 
used for RNA sequencing. After short reads having been obtained, the resulting reads are either mapped to a 
reference genome, reference transcripts or assembled de novo without the genomic sequence. The reads can be 
classified into three types: exonic reads, junction reads and poly(A) end-reads. These three types are used to 
generate a genome scale transcription map that contains both the transcriptional structure or level of  gene 
expression.  
RNA sequencing is often used to perform transcriptome profiling, the identification of novel transcripts, 
expressed SNPs, alternative splicing, and detection of gene fusion15. 
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Figure 4: mRNA sequencing overview (Nature Review Genetics, 2018) 
 
1.4.2.3 ChIP sequencing 
 
 
Chromatin immunoprecipitation followed by sequencing is popular in sequencing techniques to study genome-
wide protein-DNA interactions. The approach of ChIP sequencing combine chromatin immunoprecipitation 
with DNA sequencing to identify the binding sites of DNA associated proteins16.  
In a ChIP-seq workflow, DNA sequences that has been bound to protein by crosslinking is sheared and the 
bound DNA reads are pulled by immunoprecipitation. After been purified, the reads are converted a library of 
cDNA fragments for sequencing (Figure 5). The results will provide the binding sites for the proteins of interest. 
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Figure 5 ChIP sequencing overview (Stuart M. Brown) 
 
1.5 Bioinformatics analysis 
 
 
Despite there are many benefits of next-generation sequencing, the data generated are challenging to work with. 
The next-generation sequencing has a much higher error rate than Sanger sequencing. Furthermore, the next-
generation sequencing only produces short fragments, ranging from 100-300 nucleotides in length as well as 
the datasets are very large, always larger than 100 gigabytes17. The next-generation sequencing experiments 
must be analyzed by a robust, efficient and statistically principles pipeline to get significant results. A number 
of experimental and bioinformatics innovations are explored to help us address these challenges. 
Bioinformatics is an interdisciplinary field that uses computational approaches including collection, storage, 
retrieval, manipulation and modelling for data analysis, visualization and prediction through the development 
of algorithms and software to extract knowledge from experimental data. Bioinformatics analysis is wide used 
in high-throughput data-generating experiments, including genomic sequence determinations and 
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measurements of gene expression. The bioinformatics analysis allows us to determine whether the data are 
consistent with the hypothesis.  
 
Chapter 2: Materials and Methods 
 
 
2.1 Cell purification 
 
 
Retinal ganglion cells (RGCs) were purified from embryonic day 18, postnatal day 0, 5  and adult mice 
eyes single cell suspension by immunopanning for Thy1 (CD90, MCA02R, Serotec) after depletion of 
macrophages (using anti-mouse macrophage antibody, AIA31240, Accurate Chemical) and washing off 
the non-adherent cells, following an established protocol18. There are two replicates of each age and five 
mice’s eyes were collected in each replicate.  
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Figure 6 Representative image of P5 RGCs immunostained for RGC marker Brn3A and neuronal 
marker Tuj1, at 12 hours in culture after immunopanning (Scale bar, 100 µm). 
 
2.2 RNAseq library 
 
 
Before sequencing, highly abundant ribosomal RNAs must be removed from the sample so that mRNA can 
be detected to perform transcriptome profiling15. Polyadenylation is the addition of a polyA tail to a messenger 
RNA. In eukaryotes, polyadenlation is a part of the process that produces mature mRNA for translation. Since 
most messenger RNAs contain a polyA tail while structural RNAs do not have them, we used polyA selected 
RNA method in our experiment. The polyA RNA selection technique enables the rapid and highly specific 
enrichment of polyadenylated RNAs from total RNA samples. The embryonic day 18 and postnatal day 5 
sample libraries that were prepared from polyA-selected RNA sequenced 100bp from each ends on HiSeq 
2000 Sequencer (Illumina)19 20. All samples from different ages included two biological replicates for raw reads. 
 
2.3 ChIPseq library 
 
 
In ChIP-seq analysis, the small cell number populations of purified retinal ganglion cells result in low put ChIP-
seq reads. We used the kits which improve DNA sequencing result by covering more of the genome can 
overcome this limitation. The histone 3 acetylated at K27 (H3K27ac) is an epigenetic marker of active 
enhancers while the histone 3 acetylated at K4 trimethylation can mark active promoters which absent in the 
H3K27ac DNA regions. We used H3K4me3 to identify active enhancers and found the regions of active 
enhancers by H3K27ac in ChIP-seq pulling chromatin. Purified retinal ganglion cells were chemically cross-
linked to their bound DNA by formaldehyde treatment. We used the truChIP Ultra Low Cell Chromatin 
Shearing Kit (Covaris) and M220 Focused-ultrasonicator (Covaris) to isolate and shear the chromatin with the 
parameters recommended by the manufacturer for small cell number that lead to excellent ChIP-seq 
performance in other studies21 22.  After that, we used Zymo-Spin ChIP kit (Zymo), which is used to optimize 
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for small input amounts of chromatin from mammalian cells. It also has been validated on the material 
generated using Covaris methods.  Immunoprecipitations were performed overnight after clearance using the 
anti-H3K27ac antibody, which were validated for ChIP-seq in mouse cells and Protein G Magnetic Beads 
(Pierce).  For each age, two biological replicates and a non-ChIP’ ed sheared chromatin control were generated. 
Libraries were prepared from purified ChIP DNA using the Accel-NGS 2S Plus Kit (Swift Biosciences) that 
utilizes a proprietary adapter attachment chemistry which can decrease the bias and support inputs as low as 10 
pg. All samples from different ages included two biological replicates for raw reads. 
ChIP-seq samples were sequenced by NextSeq (Illumina) at the depth of 16M PE read. Raw data from the 
Next-generation sequencing machine often display in FASTQ format, which contain short DNA sequence and 
quality scores. Quality controlled (QC) can be used before reads mapping to help excluding reads with low 
quality16.  We used FastQC to remove adapters and trim reads. FastQC provides a simple way to do quality 
control check on raw sequence data coming from high throughput sequencing machines so that we can get the 
information whether the data has any problems before further analysis. The process of quality control can filter 
out the reads whose Phred quality score < 28 and length < 40. The Phred quality score is a standard that measure 
the quality of the identification of the bases generated during the DNA sequencing so that we can use it to 
characterize the quality of DNA sequences. 
 
2.4 RNA-seq bioinformatics pipeline 
 
 
2.4.1 Reads mapping 
 
 
A number of computational and statistical tools have been used to analyze high-throughput sequence data. At 
first, the RNA-seq reads (FASTQ files) that were generated from the HiSeq 2000 Sequencer (Illumina) were 
trimmed by Trimmomatic. Trimmomatic is a fast and flexible command line tool that can be used to trim and 
crop FASTQ file generated by the Illumina as well as to remove adapters23. With the help of Trimmomatic, 
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FASTQ files were removed technical sequences and filtered with the quality scores. After trimming, the new 
FASTQ files were mapped to the mouse reference genome which is from the GENCODE database (Version 
M13) by Hisat2. Hisat2 is an ultra fast and sensitive mapping tool to align the next-generation sequencing reads 
to the reference genome, using a hierarchical Graph FM index. The large small GFM indexes can collectively 
cover the whole genome and the global GFM index can represent a population of whole genome. The output 
of Hisat2 is BAM file. VM13 mouse reference genome containing the comprehensive gene annotation on the 
reference chromosomes is used as the reference genome. We get the BAM files from the retinal ganglion cells 
of embryonic day 18 mouse and postnatal day 5 mouse. 
 
2.4.2 Transcripts assembly 
 
 
Cufflinks packages contain a set of tools to assembly transcripts and do some differential expression analysis 
for RNA-seq data. The RNA-seq experiments always produce enormous volumes of raw sequencing reads 
data. Cufflinks is a software tool that developed with mathematics, statistics and computer science idea together. 
Cufflinks is used to assemble the reads from the aligned BAM file generated by the Hisats2 into transcripts. 
Cuffmerge merges two or more transcript assemblies while Cuffdiff is used to take the aligned reads from 
several conditions to find differentially expressed genes and transcripts using a rigorous statistical analysis 
(Figure 7)24. 
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Figure 7 An overview of Cufflinks workflow. 
 
2.5 ChIP-seq bioinformatics pipeline 
 
 
2.5.1 Reads mapping 
 
 
The reads that were generated from the sequencer were mapped to the mouse reference genome which is from 
the GENCODE database (Version M13) by Bowtie2. Bowtie2, which combines the strengths of the full-text 
minute index with the flexibility and speed of hardware-accelerated dynamic programming algorithms, is an 
ultrafast and memory-efficient mapping tool for aligning DNA reads to reference genome25 26. The index and 
algorithms can help Bowtie2 to achieve a combination of high speed, sensitivity and accuracy26. The output of 
the Bowtie2 are SAM file, which is sequence alignment map format file. SAM is a text-based format file that 
can store biological sequences aligned to a reference genome so that it is widely used to store data generated by 
next generation sequencing technologies.  
Since the binary version of SAM files (BAM) are often the input files needed for different analysis program, 
SAM files are converted to BAM files by SAMtools. SAMtools can provide a set of computational tools that 
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are used in next-generation sequence analysis to manipulate alignments in the SAM and BAM format. Binary 
file is an efficient computer file and usually much smaller than a text file that contains an equivalent amount of 
data. In terms of memory, storing values using numeric formats tends to use less memory so that it is easy to 
access by computer.  
BAM was compressed. After converting, BAM files were sorted by SAMtools because sorting helps to give a 
better compression ratio. The similar sequences are grouped together while the unmapped reads are put at the 
end of the file. 
 
 
Figure 8: Paired end reads of sequencing data mapped to reference genome 
 
2.5.2 Remove duplicates 
 
 
The next practice is to remove duplicate reads, namely just keep one read per genomic position, strand and 
sequencing library27. In the DNA sequencing, each nucleotide in the target DNA position is sequenced multiple 
times to overcome the high error rate. The number of reads that include the target nucleotide is referred to as 
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coverage. There is the assumption that since sequencing errors are random, if each nucleotide is sequenced 
multiple times, most reads will give us the correct genetic sequence. Therefore, making a deeper coverage is 
more reliable to determine the nucleotide in the target position17. Polymerase chain reaction (PCR) duplicates 
are sequence reads that result from multiple sequencing times of the same DNA fragment which may contain 
erroneous mutation introduced during PCR amplification17. PCR duplicates can lead to impediment to the data 
analysis. The main purpose of removing duplicates in ChIP-seq data is to mitigate the effects of PCR 
amplification bias introduced during library construction. In addition, after removing duplicates, the data can 
be gained the computational benefits of reducing the number of reads to be processed in downstream steps. 
The Picard is a set of command line tools which can manipulate high-throughput sequencing data. When 
preparing ChIP-seq samples, duplicates can arise during library construction. One of the functions of Picard is 
to locate and tag duplicate reads in the BAM or SAM files - MarkDuplicates. MarkDuplicates identifies read 
pairs with the same 5’ start position in the alignment process. After duplicates reads are collected, Picard 
differentiates the primary and duplicates reads by an algorithm that can rank reads by the sums of their quality 
scores. The BAM files are marked duplicates using Picard to identify duplicate reads.  The output of Picard 
MarkDuplicates was a new BAM file, in which duplicates had been identified and marked by setting the SAM 
flag 1024 for all but the best read. The best read pair was the one with the highest sum of quality scores. After 
that BAM files were removed the duplicates that were marked by Picards through SAMtools. 
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Figure 9 The duplicate reads in raw sequencing data 
 
2.5.3 Peak calling and identification 
 
 
Peak calling is a computational method used to identify the sites of protein that DNA binding by identifying 
regions where are enriched with mapping reads. The peak is the region that ChIP-seq reads are enriched 
(Figure 10). 
 
Figure 10: ChIP-seq peak and the coverage of ChIP-seq reads. 
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After mapping sequence reads to the genome, we used an algorithm, named Model-based Analysis of ChIP-
seq (MACS2) to identify transcription factor binding sites. MACS2 is a computational algorithm that 
identifies genome-wide locations of protein binding sites or histone modification from ChIP-seq data. It 
captures the influence of genome complexity to evaluate the significance of enriched reads regions and 
improves the spatial resolution of binding sites since it combines the information of both sequencing tag 
position and orientation. There are four main steps in MACS2 analysis: removing redundant reads, adjusting 
read position, calculation peak enrichment, and estimating the empirical false discovery rate (Figure 11)28. 
The control samples are used in the peak calling to increase the specificity. 
 
 
Figure 11: Workflow of MACS2 
 
The first step of MACS2 is removing redundant reads. With a high sequencing coverage, over amplification 
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of DNA fragments come from ChIP-seq data by polymerase chain reaction (PCR) may cause the same read 
to be sequenced repeatedly. MACS2 is designed to remove the redundant reads at first based on the 
parameter set by user without changing the input experiment mapped ChIP-seq reads and control reads to 
yield more reliable peak calls for downstream analysis. MACS2 will keep no more than one read per 
genomic location and remove the same one if using default option28. 
The next step is to adjust read position based on fragment size distribution. During the sequencing, the short 
fragments is equally to sequenced the 5’ end of either strands. The reads mapped to the positive and negative 
strands are likely to appear to position offsetting to the left and right of the real interaction location, resulting 
in a bimodal enrichment pattern flanking the precise interaction location. In order to extend ChIP-seq reads to 
represent the original ChIP-DNA fragments, MACS2 first slides a window with a width of about twice the 
size of the sheared chromatin to identify regions of moderate enrichment and for each peak, MACS2 will 
calculate the reads from the positive and negative strands separately (Figure 10). All the reads that from the 
positive and negative strands are extended in the 3’ direction until the estimated DNA fragment size d is 
gained28. 
After Adjusting, MACS2 slides the size 2d window to identify the regions that are significantly enriched in 
reads across the genome (Figure 12). There are many factors affect the reads enrichment distribution. To 
minimize the error, MACS2 uses the dynamic parameter λlocal to model the number of reads from a genomic 
region as a Poisson distribution. Considering the local factors, dynamic λlocal has been used to vary along the 
genome instead of a constant value of λ. Based on the Poisson distribution, MACS2 calculates an enrichment 
p-value for every candidate region and those that lowering the threshold are reported as the final peaks.  
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Figure 12: MACS2 slide window to adjust read position based on the fragment size. 
 
Finally, MACS2 uses the control sample to estimate the empirical false discovery rate (FDR) for every peak 
by exchanging the ChIP-seq and control samples and identifying peaks in the control sample with the same 
parameters used for the ChIP-seq sample. Any peaks that are identified in the control sample are regarded as 
false positives. 
Before the peak calling, I used DeepTools to generate bedGraph files from the BAM files, which was the 
required input file format of MACS2 bdgpeakcall function. DeepTools is a suite of python tools developed 
for efficient analysis of high-throughput sequencing data. The function I used was bamCoverage and set the 
binSize as 1000. The function bamCoverage takes an alignment of reads as input and generates a coverage 
track (bigwig or bedGraph) as output. The coverage is calculated as the number of reads per bin. The 
bedgraph format allows display of continuous-valued data in track format. The data exported in the bedGraph 
format are preserved in their original state. 
In the peak calling step, I used the bdgpeakcall function for narrow peak calling setting the estimated 
fragments size as 200. 
 
2.5.4 Differential binding analysis of ChIP-seq peak data 
 
 
DiffBind is a R Bioconductor package that provides options to do some differential binding analysis for ChIP-
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seq peak data. DiffBind works primarily with peak regions that associates mapped sequencing reads and the 
score indicating the strength of the peak together to help downstream analysis.  
At first, DiffBind reads in a set of peaksets from the MACS2 and associates metadata. Those peaksets can 
provide an insight into the potential occupancy of the proteins that identified by ChIP-seq. DiffBind can perform 
some plotting to determine how the occupancy maps agree with other samples such as between biological 
replicates or within groups of samples representing a common condition. The output of the occupancy analysis 
is like a consensus peakset, which represent an overall set of candidate binding sites for further analysis. Then 
DiffBind uses the sequence reads files to count the number of reads that overlap each peak for each sample. In 
order to give more standardized peak regions, DiffBind re-centers and trims peaks in the consensus peakset by 
calculating their summits. The result of counting uses the normalized read counts for each sample at potential 
protein binding site to form a binding affinity matrix in which the samples can be re-clustered using affinity. 
The main function of DiffBind is the differential binding affinity analysis. After establishing a contrast that 
divide the samples into groups to be compared, the binding sites that are statistically significantly differentially 
bound between sample groups can be identified using the DESeq2 algorithm. Each candidate binding site will 
be assigned a p-value and false discovery rate to indicate confidence that they are differentially bound. Finally, 
the DiffBind provide functions to report and plot the results to give an overview of the results of the analysis29. 
I used Diffbind to do differential peak analysis and generate correlation heatmap. Fragment size was set to 300, 
as appropriate for enhancers, while summit was set to 200. DBA_SCORE_RPKM_FOLD was set as the 
algorithm to normalize the data.  
 
2.6 Visualization of the expression profiling with the ChIP-seq peaks 
 
         
After getting the results from the RNA-seq and ChIP-seq result, I used Integrative Genomics Viewer (IGV) to 
scale the large data sets and flexibly integrate multiple data types together. IGV is a visualization tool for 
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interactive exploration of large and integrated genomic datasets. It supports integration of a large scale of 
genomic data types like aligned sequence reads and gene annotation 30.  
I used the IGV to visualize the integration of ChIP-seq peak files from two samples, gene expression profile 
that performed by RNA-seq and mouse enhancers and promoters identified in multiple tissues from ENCODE 
database together to give an epigenetic profiling of active enhancers in mouse retinal ganglion cells and 
compare them with the known enhancers and promoters. The known enhancer and promoter data were from 
the 19 types of tissues and cells. The same experiment was applied to a diverse set of tissues and cell types in 
the mouse to produce a map of about 300000 murine of cis-regulatory sequences31. The ENCODE database 
define tissue-specific enhancers and promoters and I merged the data of enhancers and promoters respectively. 
 
2.7 Motif analysis 
 
 
2.7.1 Motif discovery 
     
 
A motif is a sequence pattern that occurs in a group of related sequences repeatedly. To predict which 
transcription factors that are expressed in retinal ganglion cells can bind to the active enhancers, I used HOMER 
software to annotate the peaks and find sequence motifs through them. Hypergeometric Optimization of Motif 
Enrichment (HOMER) is a suite of tools for motif discovery and next-generation sequencing data analysis. 
HOMER can be used as a de novo motif discovery algorithm to find 8-12 base pair motifs in a large genomics 
data. I used HOMER findMotifsGenome to analyze genomic positions for enriched motifs through ChIP-seq 
peak regions. This will perform de novo motif discovery and also check the enrichment of known motifs32. The 
input files of the motif discovery analysis is the BED file that contain the information of ChIP-seq peaks such 
as chromosome, start & end position and the type of strand. The - size parameter was set as 400 to tell HOMER 
what the size of the ChIP-seq peaks. The HOMER will first verify the peak file to make sure that it is contained 
valid and unique peaks without replicates. Then sequences are extracted from the genome corresponding to the 
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regions of the peaks. HOMER select background regions as a control for motif discovery randomly to support 
a reliable result. There is a unique procedure that is provided by HOMER. The sequence would be normalized 
to remove bias introduced by lower-order oligo sequences. Finally, HOMER looks for enriched motifs in the 
peak regions with a n assigned p-value by screening the library of reliable motifs against the target and 
background sequences and will give the motifs of length 8, 10, 12. The output of HOMER will provide the 
enriched motifs files from the de novo motif discovery, separated by motif length.  
 
2.7.2 Motif comparison 
     
 
After finding the enriched motifs through peak regions, I used MEME suite tools to cross-reference the enriched 
motifs to the transcription factors. The MEME suite are motif-based sequence analysis tools that help us to use 
the enriched motifs for further analysis33. Tomtom is one of the motif comparison tool in MEME suit. We can 
use Tomtom to compare one or more motifs against a database of known motifs to rank the motifs that find in 
the database and provide an alignment for each significant match between input motifs and known motifs 
database. When given query motifs, Tomtom searches them against the database of target motifs and provide 
reports for each query a list of target motifs that matched, ranked by p-value34. I chose JASPAR CORE 2018 
as target database. JASPAR is the largest open-access database of curated and non-redundant transcription 
factor (TF) binding profiles for TFs across multiple species from six different taxonomic groups. The JASPAR 
CORE data are derived from published and experimentally defined transcription factor binding sites for 
eukaryotes. A PFM summarizes the DNA sequences that an individual TF bind to by counting the number of 
occurrences of each nucleotide at each position within the TF-binding sites. The transcription factor binding 
profiles are stored as position frequency matrices (PFMs) and transcription factor flexible models (TFFMs). 
PFMs can be also converted to probabilistic models - position weight matrices (PWMs), which can be used to 
predict TF-binding sites in DNA sequences35. Figure 13 shows an example of the motif logo and position 
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frequency matrices of transcription factor klf9 which is highly expressed in the mouse retinal ganglion cells 
identified by our RNA-seq data35. By using the JASPAR database, query motifs can be compared with the 
database that contains individual TF-bind sites and the reports of the Tomtom can provide the specific potential 
transcription factors that can bind to the target motifs. 
 
 
 
Figure 13 The motif logo and position frequency matrices. 
 
2.8 Promoter motif analysis 
 
 
Motif discovery and comparison are also used in finding motifs in promoter regions of RGCs. All the genes 
that are highly expressed in RGCs (threshold is FPKM > 1) are used to perform motif analysis of their 
promoters. Promoter regions are found by the EPDnew promoter database. EPDnew is a collection of 
databases of experimentally validated promoters for selected model organisms36. EPDnew mouse database 
contains 21239 promoters which can be searched with the select tool by the EPDnew ID, ENSEMBL gene 
ID or RefSeq ID. I selected 400 base pairs as the length of promoter regions and performed the motif analysis 
including the motif discovery and motif comparison. Each motif is also associated the TFs that have the 
potential to bind to it. 
30  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 Bioinformatics pipeline 
 
Chapter 3: Analysis and results 
 
 
3.1 RNA-seq data 
 
   
The Trimmomatic dropped 18818507 (13.40%) of total 140441332 reads in embryonic day 18 polyA RNA-
Bioinformatics Pipeline 
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seq data and dropped 17116094 (12.76%) of total 134119404 reads in postnatal day 5 data using the same 
prefix pairs. According to the Histat2 reports, the over alignment rate of embryonic day 18 data is 99.78% and 
99.80% for postnatal data (Figure 15). After getting the BAM files from both ages, I merged them together to 
get a better view in the IGV so that I could find the highly expressed transcripts throughout the whole genome. 
 
 
Figure 15: The Histat2 mapping reads result of embryonic day 18 and postnatal day 5. 
The GTF files that were generated by Cufflinks could give us the FPKM value of each gene which indicated 
the expression level of it. 
 
3.2 ChIP-seq data 
 
   
Each sample that was used as the two biological replicates included RGCs purified from multiple 
mice of various ages (embryonic day 18, postnatal day 5, and adult). The data sources of each ChIP-
seq sample are showed in Figure 16. 
32  
 
Figure 16: The sources of each ChIP-seq sample BAM file. 
 
The Figure 17 shows the the probability density of the reads counts distribution in the genome for the two 
biological replicate samples. The blue and red line represent the reads counts of sample1 and sample2 
respectively. The y-axis represents the mass of read counts per bin which normalized to millions of bins. The 
figure was plotted by the R package Rsurbread, using Kernel density estimates (KDE). The counts of each 
sample were generated by the featureCounts function in Rsurbread. The density distribution was plotted by the 
dens() function in R. 
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Figure 17 Probability density of the read counts distribution in the genome for the two biological 
replicate samples (blue and red lines).  
 
629 peaks that co-enriched in two samples were statistically significant identified by Diffbind 
through MACS2 identifying peaks. The result of differential peaks analysis is displayed in Figure 
18 (Pearson correlation coefficients r are shown). 
 
 
Figure 18 Correlation heatmap of sample1 and sample2 by Diffbind. 
 
After getting the co-enriched peaks, I visualized the active enhancers detected in the RGCs (ChIP-seq peaks 
alignment to the mouse reference genome mm10) in the IGV Viewer and cross-referenced them to the mouse 
enhancers and promoters identified in multiple tissues or cell type from the ENCODE database (Figure 19). 
The tissue-specific enhancers are from bone marrow, cerebellum, cortex, heart, limb, liver, intestine, kidney, 
lung, mouse embryonic fibroblast, embryonic stem cells, olfactory bulb, placenta, spleen, testis and thymus. I 
discovered a number of novel enhancers that maybe only specific to retinal ganglion cells because we used 
highly purified retinal ganglion cells which only comprise 1% of all retinal cells. 
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Figure 19 IGV Viewer visualization of peaks alignment to the mouse genome (mm10) and cross-
reference to the ENCODE database of mouse enhancers and promoters. 
 
The scatter plot (Figure 20) indicates correlation between concentration of peaks that are co-enriched in 
biological replicate samples. The concentration value of each sample was derived from normalized read 
counts of the 629 peaks co-enriched in each sample. Read counts normalized by FPKM are shown as log2. 
Concentration values were generated with Diffbind using the dba.report() function. Peak overlap parameters 
were set as minOverlap = 2, summits = 200 and peaks normalization function was set as 
DBA_SCORE_RPKM_FOLD. I used ggplot2 to generate the scatter plot. The Pearson correlation 
coefficient r is 0.9 (p < 0.001, two-tailed). Density of the overlapping data points was color-coded with the 
scale bar of color on the right. 
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Figure 20 Scatter-plot of the peaks concentration of sample1 and sample2.  
 
The active enhancer peaks were annotated by HOMER. TSSs from genes expressed in RGCs at least 1 
FPKM, as determined by RNA-seq profiling of purified RGCs from multiple mice of various ages, were used 
for computing the distances. TSSs and entries for non-expressed or the value of FPKM<1 were filtered out 
from the GTF file that used in HOMER for peaks annotation and calculations of distances from TSSs. Then 
probability density of peaks distances from the nearest downstream TSS that is active in RGCs was plotted 
with R package Rsurbread, using Kernel density estimates (KDE). The density distribution was plotted using 
the dens() function. Y-axis shows the mass of peaks per kb log10 (Figure 21). 
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Figure 21: Probability density of peaks distances from the nearest TSS that is active in RGCs. 
 
Figure 22 displays the distribution of peaks’ annotated genes ranked by expression percentiles after filtering 
out non-expressed genes in RGCs. The genes that annotated genes were ranked by their expression 
percentiles (100% = max expression). The distributions of genes are shown before (red line) and after (blue 
line) filtering out non-expressed or FPKM < 1 in RGCs genes. The values of FPKM were determined by 
RNA-seq profiling of purified RGCs from multiple mice of various ages. The distribution of genes’ 
expression percentiles was plotted with R-package Rsubread, using Kernel density estimates (KDE). Density 
distribution was plotted by the den() function. Mass of genes per percentile are showed on y-axis. 
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Figure 22: Probability density of peaks annotated by their expression percentile (100% = max 
expression) 
 
A bar plot was generated to show the average expression of genes (two-tailed; error bars, 1 SEM). As the bar 
plotted shown (Figure 23), the average expression of peaks annotated genes is significantly higher after 
filtering, demonstrating improved predictive power compared to default unfiltered HOMER peak annotation 
based on all mouse genes. The p value that was tested by t-test is less than 0.0001. 
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Figure 23: A bar plot that shows the average expression of genes (two-tailed; error bars, 1 SEM). 
 
By motif discovery tool HOMER, I identified 74 enriched motifs through active enhancers that were found 
by ChIP-seq data in RGCs. After comparing to the JASPAR database, transcription factors filtered by the 
expression level in RGCs were associated to each motif, as show in Table 1. Each motif is counted through 
the peaks and given the result of the number of times occur in peaks, the number of peaks in which this motif 
is found at least once, the number of TFs that have the potential to bind to it and the FPKM value of the TFs 
that express in RGCs. 
 
3.3 Motif analysis 
 
 
I next focused on the distribution of enriched motifs and Transcription factors(TFs) that are expressed in 
RGCs by peaks. The pie graph (Figure 24) indicates the distribution of transcription factors that are expressed 
in RGCs. The transcription factors are classified into three types. The first one is transcription factors that their 
transcription factor-binding sites are associated with motifs found in the identified peaks, while the second 
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type is transcription fators that their transcription factor-binding sites are associated with motifs that are not 
found in the identified peaks. The last type of transcription factors are those their transcription factor-binding 
sites are unknown to data. 32% of the transcription factors that are expressed in RGCs can be found enriched 
motifs through identified peaks in RGCs.  
 
 
Figure 24: Distribution of TFs that are expressed in RGCs. 
 
Probability density plot of identified motifs and transcription factors per peak is shown in Figure 25. The red 
line is the probability density line of enriched motifs per identified peaks. The blue line displays the density 
distribution of highly expressed transcription factors per identified peaks based on known associations with 
the identified motifs. KDE number distribution and density plot of R package are used in the figure. Y-axis 
shows the mass of numbers per peak. 
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Figure 25: Probability density of identified motifs and TFs per peak. 
 
Figure 26 and Figure 27 demonstrate the distribution of transcription factors that have associations with the 
enriched motifs and the distribution of enriched motifs through identified enhancers and promoters. The total 
number of transcription factors that are found in the enhancers and promoters is 277. 219 of them are found 
from the enhancers with the proportion of 79%. 119 of the transcription factors are found within the enriched 
motifs from the promoter, while 61 of them are overlapped by the transcription factors in enhancers. As for 
the distribution of enriched motifs, 81.4% of total motifs are found through the enhancers, while 55% of the 
motifs can be found in the promoters. 
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Figure 26: Distribution of TFs that have associations with the enriched motif through identified 
enhancers and promoters.  
 
 
Figure 27: Distribution of enriched motifs through identified enhancers and promoters. 
 
Two bar plots were generated to show the occurrence of motifs in enhancer peaks and promoter peaks 
respectively. The bar plot of Figure 28 shows the enhancer motifs occurrence, while the Figure 29 displays 
the promoter motifs occurrence. The occurrence of promoter motifs is higher than the occurrence of enhancer 
motifs. The p value that was tested by t-test is less than 0.0001in both situations. 
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Figure 28: The bar plot of enhancer motif occurrence within enhancer peaks and promoter peaks 
(two-tailed; error bars, 1 SEM). 
 
 
Figure 29: The bar plot of promoter motifs occurrence within promoter peaks and enhancer peaks 
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(two-tailed; error bars, 1 SEM). 
 
Figure 30 shows the position of the ChIP-seq peak in biological replicates (the first and the second tracks), 
and the first downstream gene, Rab10, that is expressed in RGCs, as shown in the track below. Last track 
shows positions of the known mouse enhancers from multiple cell types, including one that matched the 
enhancer identified in RGCs. 
 
Figure 30: Example 1 of enhancers and downstream genes 
 
Figure 31 shows the position of the ChIP-seq peak in biological replicates (the first and the second tracks), 
and the first downstream gene, Dpp9, as well as following genes Mir7b, Fem1a, Uhrf1 and kdm4b, which are 
all highly expressed in RGCs, as shown in the track below. Last track shows positions of the known mouse 
enhancers from multiple cell types, without a match to the novel enhancer that is identified in RGCs. 
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Figure 31: Example 2 of enhancers and downstream genes 
 
Figure 32 shows the position of the ChIP-seq peak in biological replicates (the first and the second tracks), 
and the first downstream gene, Pla2r1, which is expressed in RGCs, as shown in the track below. Enlarged 
peak is shown below. The peak is a novel enhancer, as there were no matches in the database of known 
enhancers. Positions of known motifs within the enhancer, as predicted by HOMER, are indicated (5 of 6 
motifs are unique). Two groups of3 motifs each are within sufficient proximity (within each group) for the 
TFs that bind to them to form transcriptional complex. TFs expressed in RGCs with TF-binding sites within 
these motifs are shown under each motifs, along with their corresponding TF-binding sites nucleotide 
consensus sequences logos, respectively. 
 
 
Figure 32: Motifs and TFs associated with enhancers 
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Chapter 4: Discussion 
 
 
I integrate the mRNA-seq and ChIP-seq data to generate the epigenetic H3K27ac profiling of active 
enhancers in purified mouse RGCs and predicte 629 active enhancers through the genome. After being 
compared to the enhancers identified in multiple cell types from ENCODE database, I discovered that about 
half of the enhancers active in RGCs are known from other mouse cell types, and other half are putative novel 
enhancers that may be unique to RGCs and other, potentially also rare, cell types. 
The 629 peaks are annotated by HOMER to reference to the nearest gene that has the potential to be regulated 
by the corresponding enhancer. Accuracy of peak annotations using HOMER is significantly improved if GTF 
file is filtered to exclude non-expressed genes.  
TF-binding sites motif analysis in the peaks identified 71 known motifs and predicted 3 novel motifs, which 
may be unique to RGCs. Each known motif has one or more TFs expressing in RGCs that have potential to 
bind to it. 184 of TFs expressed in RGCs matched the TF-binding sites motifs in the peaks. 
TF-binding sites proximity analysis in the peaks predicted the TFs that could form transcriptional complexes 
to regulate gene expression in RGCs.
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